Practical Management of Systemic Sclerosis in Clinical Practice
Description
Practical Management of Systemic Sclerosis in Clinical Practice describes a range of problems and clinical items encountered by a variety of medical professionals who encounter these patients. It is a valuable resource for rheumatologists, immunologists, specialist nurses and primary care professionals.
More details
Other editions
Additional editions
Persons
Marco Matucci-Cerinic is Professor of Rheumatology at the Department of Experimental and Clinical Medicine of the University of Florence. Dr Matucci-Cerinic has published more than 900 peer review manuscripts widely in the field of rheumatology, particularly on the pathogenesis, clinical features and treatment of scleroderma, on spondyloarthritis and on osteoarthtritis. Dr Matucci-Cerinic has served as EULAR General Secretary and as Chairman of the EULAR Scleroderma Trial and Research Group (EUSTAR). He is currently chairman of the World Scleroderma Foundation and Editor in Chief of the Journal of Scleroderma & Related Diseases. He is also Associate Editor of Arthritis Research & Therapy and Clinical & Experimental Rheumatology, past Associate Editor and Co-Editor of Rheumatology. He serves on the boards of Annals of the Rheumatic Diseases, Rheumatology, Journal of Rheumatology, Scandinavian Journal of Rheumatology, Therapeutic advances in musculoskeletal diseases and other rheumatology journals.
Professor Denton studied medicine at Guy's Hospital in London and obtained a PhD from University College London and trained in connective tissue diseases in London. Following a Wellcome Trust Advanced Fellowship in molecular genetics at the M.D. Anderson Cancer Center in Houston, USA he was an Arthritis Research UK Senior Research Fellow 2000-2010. He is Professor of Experimental Rheumatology at UCL and a consultant Rheumatologist at the Royal Free Hospital in London. He has published extensively on laboratory and clinical aspects of connective tissue disease. He leads a large clinical and translational research programme in scleroderma at the Royal Free Hospital and co-ordinates multidisciplinary care for more than 1500 patients. He currently chairs the UK Scleroderma Study Group (UKSSG).
